Literature DB >> 12154222

Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur?

T Potter, D Mulherin, M Pugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12154222     DOI： 10.1093/rheumatology/41.8.953

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

1.  Care pathways in early rheumatoid arthritis.

Authors:  Sasha Bernatsky; Debbie Feldman; Ian Shrier; Karine Toupin; Jeannie Haggerty; Pierre Tousignant; Michel Zummer
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

2.  Discontinuation of methotrexate therapy in older patients with newly diagnosed rheumatoid arthritis: analysis of administrative health databases in Québec, Canada.

Authors:  Sasha Bernatsky; Debbie Ehrmann Feldman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Predictors of Medication Adherence in Patients with Rheumatoid Arthritis.

Authors:  Elizabeth Salt; Susan K Frazier
Journal:  Drug Dev Res       Date:  2011-12       Impact factor: 4.360

4.  Everyday ethics and help-seeking in early rheumatoid arthritis.

Authors:  A Townsend; P Adam; S M Cox; L C Li
Journal:  Chronic Illn       Date:  2010-07-07

5.  A retrospective review of rheumatology referral wait times within a health centre in Quebec, Canada.

Authors:  Junyi Qian; D Ehrmann Feldman; Asvina Bissonauth; Henri-André Ménard; Pantelis Panopalis; Michael Stein; Jennifer Lee; Sasha Bernatsky
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

6.  Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate.

Authors:  Amal B Abdul-Sattar; Sahar A Abou El Magd
Journal:  Rheumatol Int       Date:  2014-11-26       Impact factor: 2.631

7.  Optimal care for rheumatoid arthritis: a focus group study.

Authors:  Sasha Bernatsky; Debbie Feldman; Mirella De Civita; Jeannie Haggerty; Pierre Tousignant; Jean Legaré; Michel Zummer; Tim Meagher; Christopher Mill; Mark Roper; Jennifer Lee
Journal:  Clin Rheumatol       Date:  2010-02-03       Impact factor: 2.980

8.  Infliximab in active early rheumatoid arthritis.

Authors:  F C Breedveld; P Emery; E Keystone; K Patel; D E Furst; J R Kalden; E W St Clair; M Weisman; J Smolen; P E Lipsky; R N Maini
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry.

Authors:  Dimitrios A Pappas; Jeffrey D Kent; Jeffrey D Greenberg; Marc A Mason; Joel M Kremer; Robert J Holt
Journal:  Rheumatol Ther       Date:  2015-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.